Drug Profile
NSC 620055
Alternative Names: BAPLatest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Texas Southern University
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 28 Oct 1994 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)